Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

THE LIVINGSTON GROUP, LLC OBO INNOVATIVE VACCINE TECHNOLOGIES

Filed by OCULUS STRATEGIES, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 7, 2025
Income
Not reported
Expenses
Not reported
Filing UUID
3a873142-392e-4978-a064-06562be971bf
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

DEF · Defense

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S 2572, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Literal federal measure citations: HR 3838, S 2296, HR 4016, S 2572

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.